MDLN · Medline Inc.
$35.74
+0.16 (+0.45%)
At close · Aug 14
View the 10-K filed Feb 25, 2026
Customer concentration
— key customers 74% of revenue
Key customers — 74% of revenue (the year ended December 31, 2025)
“approximately $19.7 billion (or 69% of consolidated net sales and 74% of U.S. net sales) was from sales to member hospitals under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.”
Key customers — 69% of revenue (the year ended December 31, 2025)
“approximately $19.7 billion (or 69% of consolidated net sales and 74% of U.S. net sales) was from sales to member hospitals under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.”
5 customers — 11.3% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, our top five U.S. customers represented approximately $3.2 billion (or 11.3%) of our net sales.”
Market Cap
$46.99B
Shares
1.31B
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding MDLN
341 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| AMCAP Fund | — | 16,002,681 | $585,058,017 | 0.60% | Long | 2026-05-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 10,696,005 | $475,972,223 | 0.02% | Long | 2026-03-31 | |
| VANGUARD MID-CAP INDEX FUND | — | 7,253,782 | $322,793,299 | 0.16% | Long | 2026-03-31 | |
| Growth Fund of America | — | 8,456,090 | $309,154,650 | 0.09% | Long | 2026-05-31 | |
| MFS Value Fund | — | 6,590,752 | $240,957,893 | 0.47% | Long | 2026-05-31 | |
| Fidelity Contrafund | — | 4,978,020 | $221,521,890 | 0.14% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 3,654,754 | $162,636,553 | 0.20% | Long | 2026-03-31 | |
| American Balanced Fund | — | 3,529,275 | $157,052,738 | 0.06% | Long | 2026-03-31 | |
| MFS Growth Fund | — | 4,163,316 | $152,210,833 | 0.37% | Long | 2026-05-31 | |
| VANGUARD VALUE INDEX FUND | — | 3,107,171 | $138,269,110 | 0.06% | Long | 2026-03-31 | |
| Janus Henderson Forty Fund | — | 3,101,622 | $138,022,179 | 0.67% | Long | 2026-03-31 | |
| BlackRock Mid-Cap Growth Equity Portfolio | — | 3,734,925 | $136,548,858 | 2.43% | Long | 2026-05-29 | |
| Janus Henderson Enterprise Fund | — | 2,957,481 | $131,607,905 | 0.64% | Long | 2026-03-31 | |
| GROWTH PORTFOLIO | — | 2,843,642 | $126,542,069 | 3.85% | Long | 2026-03-31 | |
| Investment Co of America | — | 2,824,406 | $125,686,067 | 0.08% | Long | 2026-03-31 | |
| Fidelity Puritan Fund | — | 3,392,059 | $124,013,677 | 0.37% | Long | 2026-05-31 | |
| Capital World Growth & Income Fund | — | 3,377,348 | $123,475,843 | 0.08% | Long | 2026-05-31 | |
| VANGUARD U.S. GROWTH FUND | — | 2,836,409 | $103,699,113 | 0.22% | Long | 2026-05-31 | |
| VANGUARD MID-CAP VALUE INDEX FUND | — | 2,183,408 | $97,161,656 | 0.28% | Long | 2026-03-31 | |
| MFS Mid Cap Growth Fund | — | 2,411,142 | $88,151,352 | 0.64% | Long | 2026-05-31 | |
| Invesco Main Street Fund | — | 1,759,641 | $78,251,235 | 0.69% | Long | 2026-04-30 | |
| Fidelity Extended Market Index Fund | — | 2,076,456 | $75,915,231 | 0.18% | Long | 2026-05-31 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 2,049,707 | $74,937,288 | 0.03% | Long | 2026-05-31 | |
| Fidelity Blue Chip Growth Fund | — | 1,433,771 | $63,759,796 | 0.07% | Long | 2026-04-30 | |
| First Trust US Equity Opportunities ETF | — | 1,379,146 | $61,371,997 | 5.28% | Long | 2026-03-31 | |
| VIP Growth Portfolio | — | 1,317,500 | $58,628,750 | 0.55% | Long | 2026-03-31 | |
| iShares Russell Mid-Cap ETF | — | 1,239,163 | $55,142,754 | 0.11% | Long | 2026-03-31 | |
| Fidelity Advisor Equity Growth Fund | — | 1,497,108 | $54,734,268 | 0.40% | Long | 2026-05-31 | |
| Janus Henderson Contrarian Fund | — | 1,220,588 | $54,316,166 | 1.27% | Long | 2026-03-31 | |
| T. Rowe Price Blue Chip Growth Fund, Inc. | — | 1,211,736 | $53,922,252 | 0.09% | Long | 2026-03-31 | |
| Fidelity Mid Cap Index Fund | — | 1,200,512 | $53,386,769 | 0.11% | Long | 2026-04-30 | |
| Fidelity Fund | — | 1,143,600 | $50,890,200 | 0.61% | Long | 2026-03-31 | |
| Invesco Discovery Mid Cap Growth Fund | — | 1,110,825 | $49,398,388 | 0.74% | Long | 2026-04-30 | |
| Transamerica Capital Growth | — | 1,097,744 | $48,816,676 | 3.87% | Long | 2026-04-30 | |
| Fidelity Contrafund K6 | — | 1,066,202 | $47,445,989 | 0.14% | Long | 2026-03-31 | |
| T. Rowe Price Growth Stock Fund, Inc. | — | 1,037,616 | $46,173,912 | 0.10% | Long | 2026-03-31 | |
| Select Medical Technology and Devices Portfolio | — | 1,250,000 | $45,700,000 | 1.54% | Long | 2026-05-31 | |
| Parnassus Mid Cap Fund | — | 1,005,600 | $39,660,864 | 1.57% | Long | 2026-06-30 | |
| Janus Henderson Global Life Sciences Fund | — | 864,511 | $38,470,740 | 0.74% | Long | 2026-03-31 | |
| Fidelity Growth Company Fund | — | 1,051,120 | $38,428,947 | 0.04% | Long | 2026-05-31 | |
| Growth-Income Fund | — | 836,100 | $37,206,450 | 0.09% | Long | 2026-03-31 | |
| Select Health Care Portfolio | — | 1,000,000 | $36,560,000 | 0.63% | Long | 2026-05-31 | |
| Fidelity Advisor New Insights Fund | — | 763,415 | $33,971,968 | 0.14% | Long | 2026-03-31 | |
| iShares Russell 1000 Value ETF | — | 741,742 | $33,007,519 | 0.05% | Long | 2026-03-31 | |
| Fidelity Growth Discovery Fund | — | 711,300 | $31,652,850 | 0.55% | Long | 2026-03-31 | |
| Artisan Mid Cap Fund | — | 696,777 | $31,006,577 | 1.05% | Long | 2026-03-31 | |
| VIP Contrafund Portfolio | — | 691,500 | $30,771,750 | 0.12% | Long | 2026-03-31 | |
| Federated Hermes Kaufmann Fund | — | 656,800 | $29,207,896 | 0.63% | Long | 2026-04-30 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 775,489 | $28,351,878 | 0.15% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 760,925 | $27,819,418 | 0.02% | Long | 2026-05-31 |
Showing 1–50 of 341 positions
Key facts
CIK
2046386
CUSIP
58507V107
13F (30d)
387 filings
386 filers
Visit website
Investor relations